Kuala lumpur: Malaysia is cementing its position as Asia's clinical research hub as Clinical Research Malaysia (CRM) launched CRM Trial Connect 2026, drawing more than 1,100 participants from across the global healthcare, regulatory and research ecosystem.

According to BERNAMA News Agency, the event, themed 'Asia's Rise in Clinical Trials,' is the fifth edition of CRM Trial Connect and highlights the region's growing influence in global drug development. The previous year's event resulted in over 60 collaborations, which generated RM70 million in value and significantly advanced clinical research across Asia.

The CRM Trial Connect 2026 serves as a pivotal platform for stakeholders in the healthcare industry to collaborate and innovate, further establishing Malaysia as a leader in clinical research within Asia. The event's success underscores Malaysia's strategic role in shaping the future of global healthcare and research.